Skip to main content

Advertisement

Log in

This thought is as a death

  • Multi-author review
  • Published:
Cellular and Molecular Life Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Acknowledgments

The authors received funding by the German research foundation (DFG) in the Cluster of Excellence, Inflammation at interfaces (EXC 306), Kiel, Germany (DA and AL) and the SFB 877 (DA), as well as the Deutsche Krebshilfe (110055, DA).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dieter Adam.

Ethics declarations

Conflict of interest

A.L. declares to have received research grants from Pfizer, Novartis, Fresenius Medical Care and the Else Kröner-Fresenius Stiftung. Further, the research is supported by Genentech, Glaxo Smith Kline and Apogenix (material transfer agreements). In addition, A.L. declares to have received honoraria and/or travel grants from Astellas, Otsuka, Genentech, Alexion and Tekmira. D.A. declares no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adam, D., Linkermann, A. This thought is as a death. Cell. Mol. Life Sci. 73, 2123–2124 (2016). https://doi.org/10.1007/s00018-016-2199-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00018-016-2199-9

Keywords

Navigation